Revenue rise comes as drugmaker plans $50bn US investment in face of looming tariff threatRead More
You might also be interested in reading Bitcoin at $71K stares down the raging dollar-and-yield storm.
Revenue rise comes as drugmaker plans $50bn US investment in face of looming tariff threatRead More
You might also be interested in reading Bitcoin at $71K stares down the raging dollar-and-yield storm.